• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·China·Basic Materials·603363.SS
Share

Fujian Aonong Biological Technology Group Incorporation Limited Stocks

CN¥ 2.73Last Updated 16.11.2026

Issuer Rating

4/7
Performance

Modest

Risk

Limited

Recommendation

Hold

Market Cap

CN¥ 1.11B

CN¥ 2.73
Key Takeaways

Risk factor

Good trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very low or no dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Fujian Aonong Biological Technology Group Incorporation Limited operates across diverse sectors, including animal feed production, swine farming, agricultural raw material trading, digital agricultural platforms, and bio-pharmaceuticals, serving both domestic Chinese and international markets. Its activities encompass the research, development, manufacturing, and distribution of various animal feed products, including specialized formulations for pigs, poultry, aquatic species, and ruminants. Furthermore, the company manages pig breeding facilities and is involved in the processing and slaughtering of swine. Aonong Biological Technology also supplies a range of veterinary products, such as vaccines, medicinal preparations, micro-ecological agents, powdered supplements, premixes, liquid oral treatments, feed additives, and disinfectants. Additionally, it develops and maintains an intelligent platform designed to support breeding services. Established in Xiamen, China, the company commenced operations in 2011.

Company Valuation

Fairly valued
4/7

Based on key historical and expected multiples, the stock is fairly valued relative to its peers.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

17.11.2026 03:31

The success of the Starship tests failed to boost SpaceX's stock price. What are people saying on Wall Street?

17.11.2026 02:46

"The Music Fades": Bloomberg Names Neoclouds Vulnerable to a Change in Nvidia's Leadership

17.11.2026 02:19

The Nasdaq 100 IT Stock Index fell 2.7% at the start of a key week for the sector

17.11.2026 01:54

Alphabet will participate in $3 billion in bond transactions in the energy sector

17.11.2026 01:26

"GTA VI Is Just the Beginning": Analysts Recommend Buying Take-Two Stock Ahead of the Release

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026